+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Hyperpigmentation Disorders Treatment Market by Indication (Centrofacial Melasma, Malar Melasma, Mandibular Melasma), Treatment Type (Cosmeceuticals, Laser Therapy, Medication), End-User - Forecast 2024-2030- Product Image
Global Hyperpigmentation Disorders Treatment Market by Indication (Centrofacial Melasma, Malar Melasma, Mandibular Melasma), Treatment Type (Cosmeceuticals, Laser Therapy, Medication), End-User - Forecast 2024-2030- Product Image
Sale

Global Hyperpigmentation Disorders Treatment Market by Indication (Centrofacial Melasma, Malar Melasma, Mandibular Melasma), Treatment Type (Cosmeceuticals, Laser Therapy, Medication), End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 190 Pages
  • March 2024
  • Region: Global
  • 360iResearch™
  • ID: 5889071
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Hyperpigmentation Disorders Treatment Market size was estimated at USD 3.83 billion in 2023, USD 4.03 billion in 2024, and is expected to grow at a CAGR of 5.73% to reach USD 5.66 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hyperpigmentation Disorders Treatment Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hyperpigmentation Disorders Treatment Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hyperpigmentation Disorders Treatment Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aerolase Corporation, Asclepion Laser Technologies GmbH, BIODERMA, Candela Corporation, Cosderma Cosmetology Institute, Cynosure LLC, Fade Out Ltd., Galderma S.A., iSCLINICAL, Lumenis Be Ltd., Lynton Lasers Ltd., Mesoestetics, Niche Beauty Lab, S.L., Obagi Cosmeceuticals LLC, PCA Skin by Colgate-Palmolive Company, Pureplay Skin Sciences (India) Private Limited, Skin Laundry Holdings LLC, Skincare by Dr V, and ZO Skin Health, Inc.

Market Segmentation & Coverage

This research report categorizes the Hyperpigmentation Disorders Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Centrofacial Melasma
    • Malar Melasma
    • Mandibular Melasma
  • Treatment Type
    • Cosmeceuticals
    • Laser Therapy
    • Medication
    • Microdermabrasion
    • Phototherapy
  • End-User
    • Dermatology Centers
    • Esthetic Centers
    • Hospitals
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Hyperpigmentation Disorders Treatment Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hyperpigmentation Disorders Treatment Market?
  3. What are the technology trends and regulatory frameworks in the Hyperpigmentation Disorders Treatment Market?
  4. What is the market share of the leading vendors in the Hyperpigmentation Disorders Treatment Market?
  5. Which modes and strategic moves are suitable for entering the Hyperpigmentation Disorders Treatment Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Hyperpigmentation Disorders Treatment Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing prevalence of hyperpigmentation disorders
5.1.1.2. Rising awareness about importance of skincare among population
5.1.1.3. Increased expenditure on cosmetics and skincare products
5.1.2. Restraints
5.1.2.1. High cost of treatments and varying output results
5.1.3. Opportunities
5.1.3.1. Technological advancements like laser treatment and needling process
5.1.3.2. Surge in R&D activities to develop novel approaches for hyperpigmentation treatment
5.1.4. Challenges
5.1.4.1. Increasing skin sensitivity, allergies and reactions to some
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Hyperpigmentation Disorders Treatment Market, by Indication
6.1. Introduction
6.2. Centrofacial Melasma
6.3. Malar Melasma
6.4. Mandibular Melasma
7. Hyperpigmentation Disorders Treatment Market, by Treatment Type
7.1. Introduction
7.2. Cosmeceuticals
7.3. Laser Therapy
7.4. Medication
7.5. Microdermabrasion
7.6. Phototherapy
8. Hyperpigmentation Disorders Treatment Market, by End-User
8.1. Introduction
8.2. Dermatology Centers
8.3. Esthetic Centers
8.4. Hospitals
9. Americas Hyperpigmentation Disorders Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hyperpigmentation Disorders Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hyperpigmentation Disorders Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. AbbVie Inc.
13.1.2. Aerolase Corporation
13.1.3. Asclepion Laser Technologies GmbH
13.1.4. BIODERMA
13.1.5. Candela Corporation
13.1.6. Cosderma Cosmetology Institute
13.1.7. Cynosure LLC
13.1.8. Fade Out Ltd.
13.1.9. Galderma S.A.
13.1.10. iSCLINICAL
13.1.11. Lumenis Be Ltd.
13.1.12. Lynton Lasers Ltd.
13.1.13. Mesoestetics
13.1.14. Niche Beauty Lab, S.L.
13.1.15. Obagi Cosmeceuticals LLC
13.1.16. PCA Skin by Colgate-Palmolive Company
13.1.17. Pureplay Skin Sciences (India) Private Limited
13.1.18. Skin Laundry Holdings LLC
13.1.19. Skincare by Dr V
13.1.20. ZO Skin Health, Inc.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. HYPERPIGMENTATION DISORDERS TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HYPERPIGMENTATION DISORDERS TREATMENT MARKET DYNAMICS
FIGURE 7. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 8. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
FIGURE 10. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HYPERPIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
List of Tables
TABLE 1. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 6. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY CENTROFACIAL MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MALAR MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MANDIBULAR MELASMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 10. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COSMECEUTICALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY LASER THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY MICRODERMABRASION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY PHOTOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY DERMATOLOGY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY ESTHETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 26. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 29. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 30. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 33. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 43. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 46. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 47. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 49. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 55. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 67. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 74. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 76. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 79. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 83. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 84. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 86. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 90. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 92. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. GERMANY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 96. GERMANY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 98. ISRAEL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. ITALY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 102. ITALY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 104. NETHERLANDS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 107. NIGERIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. NORWAY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 111. NORWAY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 113. POLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 114. POLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 116. QATAR HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 117. QATAR HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 119. RUSSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 128. SPAIN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 129. SPAIN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. SWITZERLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 137. TURKEY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 138. TURKEY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 140. UNITED ARAB EMIRATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 143. UNITED KINGDOM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM HYPERPIGMENTATION DISORDERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. HYPERPIGMENTATION DISORDERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 147. HYPERPIGMENTATION DISORDERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 148. HYPERPIGMENTATION DISORDERS TREATMENT MARKET LICENSE & PRICING

Companies Mentioned

  • AbbVie Inc.
  • Aerolase Corporation
  • Asclepion Laser Technologies GmbH
  • BIODERMA
  • Candela Corporation
  • Cosderma Cosmetology Institute
  • Cynosure LLC
  • Fade Out Ltd.
  • Galderma S.A.
  • iSCLINICAL
  • Lumenis Be Ltd.
  • Lynton Lasers Ltd.
  • Mesoestetics
  • Niche Beauty Lab, S.L.
  • Obagi Cosmeceuticals LLC
  • PCA Skin by Colgate-Palmolive Company
  • Pureplay Skin Sciences (India) Private Limited
  • Skin Laundry Holdings LLC
  • Skincare by Dr V
  • ZO Skin Health, Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages190
PublishedMarch 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 4.03 Billion
Forecasted Market Value ( USD ) by 2030 $ 5.66 Billion
Compound Annual Growth Rate5.7%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Hyperpigmentation Disorder Treatment Global Market Report 2024 - Product Image

Hyperpigmentation Disorder Treatment Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Hyperpigmentation Disorders Treatment: Global Strategic Business Report - Product Image

Hyperpigmentation Disorders Treatment: Global Strategic Business Report

  • Report
  • 194 Pages
  • Global
From
Hyperpigmentation Disorders Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Hyperpigmentation Disorders Treatment Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 108 Pages
  • Global
From
Hyperpigmentation Treatment Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Hyperpigmentation Treatment Device Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 105 Pages
  • Global
From
Global Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030 - Product Image

Global Pigmentation Disorder Treatment Market Size, Share & Industry Trends Analysis Report By Type (Vitiligo, Melasma), By Treatment (Corticosteroids, Calcineurin Inhibitor, and Others), By Distribution Channel, By Regional Outlook and Forecast, 2023 - 2030

  • Report
  • 238 Pages
  • Global
From

About the Hyperpigmentation Drug Market

The Hyperpigmentation Drug market is a subset of the Dermatological Drugs market, which includes medications used to treat skin conditions. Hyperpigmentation Drugs are used to treat conditions such as melasma, age spots, and post-inflammatory hyperpigmentation. These drugs are typically topical creams, lotions, or gels that contain active ingredients such as hydroquinone, tretinoin, and corticosteroids. These drugs work by inhibiting the production of melanin, the pigment that causes dark spots on the skin. The Hyperpigmentation Drug market is highly competitive, with many companies offering products that contain different active ingredients. Some of the major players in the market include Galderma, Allergan, and Johnson & Johnson. Other companies in the market include Valeant Pharmaceuticals, Merck, and Sun Pharmaceuticals. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.